Internal Your Health teams recently studied ways to improve statin use among patients living with diabetes and cardiovascular disease. Their findings point to a clear opportunity within value-based care: when eligible patients stay on the right therapy, organizations can support better outcomes while also strengthening quality performance.

The paper highlights that statin use remains an important part of cardiovascular risk reduction, especially for high-risk populations. It also identifies practical ways Your Health can help close care gaps through better education, lower cost barriers, and stronger use of existing analytics tools.

This work shows that Your Health is seeking practical, patient-centered ways to improve care delivery. By focusing on medication adherence, provider support, and targeted outreach, these findings help shape strategies that can improve both patient impact and quality performance over time.

Patients with diabetes and cardiovascular disease often face a higher risk of serious heart-related events. The paper notes that statins can help reduce that risk, but gaps in prescribing and long-term adherence still limit their full impact. Within value-based care, those gaps also affect quality measures and star ratings, making this an important area for improvement.
The research points to three practical opportunities. The first is a stronger provider, patient, and staff education so that people better understand the role statins play in long-term cardiovascular health. The second is reducing financial barriers through a no-out-of-pocket formulary approach for select medications. The third is making better use of current analytics tools to identify eligible patients, spot care gaps, and support more targeted follow-up.
Based on these findings, the paper supports a coordinated approach that brings providers, pharmacists, staff, and data tools together around one goal: helping high-risk patients stay on appropriate therapy. The most practical path forward centers on clearer education, affordable access, and more proactive outreach through existing systems.
This research shows that even modest improvements in statin use could make a meaningful difference. Better adherence can support stronger patient outcomes, improved quality performance, and a more connected approach to chronic disease management. The paper also reinforces that practical, scalable changes are often the most useful place to start.

These findings reflect one part of how Your Health teams are thinking about quality improvement in value-based care. For a closer look at the full analysis and supporting recommendations, read the full paper below.

Read Full Paper